Journal of Controlled Release, Год журнала: 2025, Номер unknown, С. 113629 - 113629
Опубликована: Март 1, 2025
Язык: Английский
Journal of Controlled Release, Год журнала: 2025, Номер unknown, С. 113629 - 113629
Опубликована: Март 1, 2025
Язык: Английский
Small, Год журнала: 2025, Номер unknown
Опубликована: Фев. 16, 2025
Abstract The field of immunotherapeutics is rapidly evolving with the advent cell therapies, complex biologics, and a host other compounds. Polymeric carriers are often used to tune safety efficacy profiles these novel drugs. Despite their prevalence in pre‐clinical clinical applications, non‐degradable materials present delivery challenges including diffusion‐limited release, frustrated phagocytosis, limited clearance. In contrast, biodegradable polymeric systems provide safer alternative addition displaying advantageous properties for immunotherapies. this review, discussion polymers poly(lactic‐co‐glycolic acid) (PLGA), poly(beta‐amino esters) (PBAEs), acetalated dextran (Ace‐DEX), chitosan, alginate, hyaluronic acid (HA) as immunomodulatory biomaterial suggest that variety can be generate tailored formulations different therapeutic payloads disease indications. These carrier enhance immunotherapies via tunable degradation rates, enhanced antigen‐presentation, inherent biomaterials, among mechanisms. Polymers formulated applications synthetic, semi‐synthetic, or naturally derived. Therefore, it crucial consider environmental impact polymer sources, particle fabrication methods, solvent usage sustainably develop effective therapies field.
Язык: Английский
Процитировано
0Journal of Controlled Release, Год журнала: 2025, Номер unknown, С. 113629 - 113629
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0